Literature DB >> 11728520

Plasma and urinary markers of oral testosterone undecanoate misuse.

Shi Hua Peng1, Jordi Segura, Magí Farré, Jose Carlos González, Xavier de la Torre.   

Abstract

Orally administered testosterone undecanoate (TU), an anabolic, androgenic steroid, can potentially be abused by athletes. Indirect evidence for detecting oral TU intake could be deduced from the changes in steroid profile post-administration. Direct evidence could be obtained by detection of unchanged TU in plasma. To this end, both urinary and plasma steroid profiles of six healthy male subjects given a single oral dose of 120 mg of TU were studied by gas chromatography/mass spectrometry (GC/MS) and gas chromatography/tandem mass spectrometry (GC/MS/MS). The increased concentration of glucuronidated testosterone in plasma appears to be the most characteristic sign of oral TU intake. The testosterone glucuronide (TG)/nonconjugated testosterone (T) ratio, TG/17-hydroxyprogesterone (17OHP) ratio, and TG/luteinizing hormone (LH) ratio were observed to be significantly elevated above their basal levels for 10 h, 10 h, and 6 h, respectively. Urinary ratios of TG/epitestosterone glucuronide (EG) were found to be higher than the cut-off value of 6 for the period 4 approximately 8 h post-administration, but only in three subjects. One subject failed to respond with respect to all of the above-mentioned indirect markers, as TG was not significantly increased in either plasma or urine. Unchanged TU was directly detected in plasma of all six subjects from 1 approximately 1.5 h to 4 approximately 6 h after oral TU intake by GC/MS/MS, providing unequivocal proof of exogenous testosterone intake. Distinct and complementary markers for detecting oral TU intake could be obtained from plasma and urine, respectively.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11728520     DOI: 10.1016/s0039-128x(01)00128-3

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  5 in total

1.  Urinary and serum hormones profiles after testosterone enanthate administration in male hypogonadism: concerns on the detection of doping with testosterone in treated hypogonadal athletes.

Authors:  L Di Luigi; P Sgrò; F Romanelli; M Mazzarino; F Donati; M C Braganò; S Bianchini; V Fierro; M Casasco; F Botrè; A Lenzi
Journal:  J Endocrinol Invest       Date:  2009-03-24       Impact factor: 4.256

2.  Variations in urine excretion of steroid hormones after an acute session and after a 4-week programme of strength training.

Authors:  Rafael Timón Andrada; M Maynar Mariño; D Muñoz Marín; G J Olcina Camacho; M J Caballero; J I Maynar Mariño
Journal:  Eur J Appl Physiol       Date:  2006-10-19       Impact factor: 3.078

3.  Reexamination of pharmacokinetics of oral testosterone undecanoate in hypogonadal men with a new self-emulsifying formulation.

Authors:  Anthony Y Yin; Michelle Htun; Ronald S Swerdloff; Maruja Diaz-Arjonilla; Robert E Dudley; Sandra Faulkner; Rachelle Bross; Andrew Leung; Sima Baravarian; Laura Hull; James A Longstreth; Steven Kulback; Gregory Flippo; Christina Wang
Journal:  J Androl       Date:  2011-04-07

4.  Profiling of Metabolomic Changes in Plasma and Urine of Pigs Caused by Illegal Administration of Testosterone Esters.

Authors:  Kamil Stastny; Kristina Putecova; Lenka Leva; Milan Franek; Petr Dvorak; Martin Faldyna
Journal:  Metabolites       Date:  2020-07-27

5.  Detectability of testosterone esters and estradiol benzoate in bovine hair and plasma following pour-on treatment.

Authors:  A A M Stolker; M J Groot; J J P Lasaroms; A W J M Nijrolder; M H Blokland; I Riedmaier; C Becker; H H D Meyer; M W F Nielen
Journal:  Anal Bioanal Chem       Date:  2009-08-26       Impact factor: 4.142

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.